Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

SOX9 Knockout Huh-7 Cell Line

The SOX9 Knockout Huh-7 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the Huh-7 hepatocellular carcinoma model. SOX9 is a master transcription factor…
Cat. No. ARG44127

SOX8 Knockout MHCC97-H Cell Line

The SOX8 Knockout MHCC97-H Cell Line is a CRISPR/Cas9-edited knockout cell line that abolishes SOX8 transcription factor function in the highly metastatic human hepatocellular carcinoma…
Cat. No. ARG44126

SOX6 Knockout A-375 Cell Line

The SOX6 Knockout A-375 Cell Line provides a CRISPR/Cas9-edited knockout model in A-375 malignant melanoma cells, disrupting the SOX6 transcription factor. SOX6 integrates Wnt and…
Cat. No. ARG44125

SORCS2 Knockout HGC-27 Cell Line

The SORCS2 Knockout HGC-27 Cell Line is a CRISPR/Cas9-edited knockout cell line enabling targeted disruption of SORCS2, a VPS10 domain sorting receptor that regulates cell…
Cat. No. ARG44124

SOAT1 Knockout Hep-G2 Cell Line

The SOAT1 Knockout Hep-G2 Cell Line is a CRISPR/Cas9-edited hepatocellular carcinoma model with targeted disruption of the SOAT1 gene, which encodes a cholesterol-esterifying enzyme. By…
Cat. No. ARG44123

Snx9 Knockout PC-12 Cell Line

The Snx9 Knockout PC-12 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the rat pheochromocytoma PC-12 line, engineered to disrupt the sorting nexin…
Cat. No. ARG44122

Snx1 Knockout RAW 264.7 Cell Line

The Snx1 Knockout RAW 264.7 Cell Line offers a CRISPR/Cas9-edited mouse macrophage model lacking sorting nexin 1, a retromer component essential for endosome-to-Golgi retrieval of…
Cat. No. ARG44121

SMPD3 Knockout HaCat Cell Line

The SMPD3 Knockout HaCat Cell Line is a CRISPR/Cas9-edited knockout cell line in which the SMPD3 gene has been disrupted in the HaCat human keratinocyte…
Cat. No. ARG44120

Smo Knockout NIH 3T3 Cell Line

The Smo Knockout NIH 3T3 Cell Line is a CRISPR/Cas9-edited knockout cell line targeting the Smoothened (Smo) gene in immortalized mouse embryonic fibroblasts. Disruption of…
Cat. No. ARG44119

SLC9A1 Knockout SK-MEL-28 Cell Line

This SLC9A1 Knockout SK-MEL-28 Cell Line is a CRISPR/Cas9-edited human melanoma model with targeted disruption of the Na+/H+ exchanger NHE1. Derived from BRAF V600E-mutated SK-MEL-28…
Cat. No. ARG44118

SLC5A2 Knockout HK-2 Cell Line

The SLC5A2 Knockout HK-2 Cell Line is a CRISPR/Cas9-edited knockout cell line in the HK-2 human renal proximal tubule epithelial background, engineered to disrupt SLC5A2.…
Cat. No. ARG44117

Slc3a2 Knockout Hepa 1-6 Cell Line

The Slc3a2 Knockout Hepa 1-6 Cell Line is a CRISPR/Cas9-edited knockout line from mouse hepatoma Hepa 1-6 cells, with targeted disruption of Slc3a2 (CD98). Slc3a2…
Cat. No. ARG44116

Loading products...